Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Mullol, J." or (type any "bookEditor journalEditor issueEditor" and editor="Mullol, J.")

Add to list
- Journal Article
- A1
- open access
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

M. Desrosiers, L.P. Mannent, N. Amin, G.W. Canonica, Peter Hellings (UGent) , Philippe Gevaert (UGent) , J. Mullol, S.E. Lee, S. Fujieda, J.K. Han, et al.

(2021) RHINOLOGY. 59(3). p.301-311
Add to list
- Conference Paper
- C3
- open access
Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps and comorbid asthma from the pooled populations of the SINUS-24 and SINUS-52 Dupilumab phase 3 trials

M. Desrosiers, J. Mullol, K. Forwith, Philippe Gevaert (UGent) , J. F. Maspero, M. Zhang, X. Mao, N. Amin and L. P. Mannent

(2020) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 201.
Add to list
Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS-24 and SINUS-52 phase 3 studies

J. Mullol, Claus Bachert (UGent) , M. Desrosiers, J. K. Han, R. Jankowski, N. Daizadeh, N. Amin, L. P. Mannent, Asif H. Khan (UGent) and S. Kamat

(2020) ALLERGY. In Allergy 75(Supplement 109). p.107-107
Add to list
Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis

Philippe Gevaert (UGent) , Peter Hellings (UGent) , J. K. Han, J. Mullol, R. Ow, P. Olsson, R. Zhao, R. Saenz, L. Islam and T. Omachi

(2020) ALLERGY. In Allergy 75(Supplement 109). p.227-227
Add to list
Omalizumab responders analysis in nasal polyposis : a supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials

J. Corren, P. H. Wellings, Philippe Gevaert (UGent) , Claus Bachert (UGent) , J. Mullol, X. Jaumont, R. Zhao, R. Saenz, L. Islam and T. Omachi

(2020) ALLERGY. In Allergy 75(Supplement 109). p.496-497
Add to list
Continued safety / efficacy of omalizumab in chronic rhinosinusitis with nasal polyps : an open-label extension study

Philippe Gevaert (UGent) , R. Saenz, J. Corren, J. Han, J. Mullol, S. Lee, R. Zhao, M. Howard, K. Wong, L. Islam, et al.

(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S15-S15
Add to list
- Journal Article
- A1
- open access
Treatment of allergic rhinitis during and outside the pollen season using mobile technology : a MASK study

A. Bedard, X. Basagana, J. M. Anto, J. Garcia-Aymerich, P. Devillier, S. Arnavielhe, A. Bedbrook, G. L. Onorato, W. Czarlewski, R. Murray, et al.

(2020) CLINICAL AND TRANSLATIONAL ALLERGY. 10(1).
Add to list
- Journal Article
- A1
- open access
Aligning the good practice MASK with the objectives of the European Innovation Partnership on Active and Healthy Ageing

J. Bousquet, J. Farrell, M. Illario, G. L. Onorato, A. Bedbrook, W. Czarlewski, Y. Micheli, S. Arnavielhe, I. J. Ansotegui, J. M. Anto, et al.

(2020) ALLERGY ASTHMA & IMMUNOLOGY RESEARCH. 12(2). p.238-258
Add to list
European position paper on rhinosinusitis and nasal polyps 2020

W. J. Fokkens, V. J. Lund, C. Hopkins, Peter Hellings (UGent) , R. Kern, S. Reitsma, S. Toppila-Salmi, M. Bernal-Sprekelsen, J. Mullol, I. Alobid, et al.

(2020) RHINOLOGY. 58(Suppl. 29). p.1-464
Add to list
- Conference Paper
- C3
Dupilumab improves patient-reported outcomes in chronic Rhinosinusitis with nasal polyps and comorbid asthma : sinus-24/sinus-52 trials

Philippe Gevaert (UGent) , Claus Bachert (UGent) , M. Desrosiers, J. Mullol, J. Maspero, M. Zhang, X. Mao, S. Kamat, A. Khan, N. Amin, et al.

(2019) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 123(5 Suppl S). p.S58-S59

Academic Bibliography

Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps and comorbid asthma from the pooled populations of the SINUS-24 and SINUS-52 Dupilumab phase 3 trials

Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS-24 and SINUS-52 phase 3 studies

Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis

Omalizumab responders analysis in nasal polyposis : a supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials

Continued safety / efficacy of omalizumab in chronic rhinosinusitis with nasal polyps : an open-label extension study

Treatment of allergic rhinitis during and outside the pollen season using mobile technology : a MASK study

Aligning the good practice MASK with the objectives of the European Innovation Partnership on Active and Healthy Ageing

European position paper on rhinosinusitis and nasal polyps 2020

Dupilumab improves patient-reported outcomes in chronic Rhinosinusitis with nasal polyps and comorbid asthma : sinus-24/sinus-52 trials

Contents

Support

Contact